Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.04
-0.49 (-3.91%)
Jul 13, 2026, 10:01 AM EDT - Market open
TNXP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 185.47 | 207.64 | 98.78 | 24.95 | 120.23 | 178.66 |
Cash & Short-Term Investments | 185.47 | 207.64 | 98.78 | 24.95 | 120.23 | 178.66 |
Cash Growth | 40.81% | 110.21% | 295.93% | -79.25% | -32.70% | 131.82% |
Accounts Receivable | 8.82 | 6.27 | 3.68 | - | - | - |
Inventory | 3.65 | 6.01 | 8.41 | 13.64 | - | - |
Other Current Assets | - | - | - | 9.18 | 10.55 | 10.39 |
Total Current Assets | 197.94 | 219.92 | 110.87 | 47.77 | 130.78 | 189.05 |
Net Property, Plant & Equipment | 46.34 | 46 | 42.82 | 94.85 | 94.53 | 51.47 |
Other Intangible Assets | 0.12 | 0.12 | 0.12 | 9.74 | 0.12 | - |
Goodwill | - | - | - | 0.97 | - | - |
Other Long-Term Assets | 4.29 | 2.18 | 0.95 | 1.13 | 0.26 | 0.38 |
Total Assets | 257.91 | 277.17 | 162.89 | 154.46 | 225.69 | 240.9 |
Accounts Payable | 9.65 | 8.11 | 4.55 | 3.78 | 8.07 | 13.28 |
Accrued Expenses | 19.84 | 22.6 | 10.67 | 12.48 | 9.68 | 7.95 |
Short-Term Debt | - | - | 2.82 | 2.35 | - | - |
Current Portion of Leases | 0.16 | 0.13 | 0.27 | 0.27 | 0.43 | 0.49 |
Total Current Liabilities | 29.65 | 30.84 | 18.31 | 18.88 | 18.18 | 21.72 |
Long-Term Debt | - | - | 4.67 | 6.56 | - | - |
Long-Term Leases | 1.13 | 1.18 | 0.36 | 0.63 | 0.33 | 0.47 |
Other Long-Term Liabilities | - | - | - | 22.86 | - | - |
Total Long-Term Liabilities | 1.13 | 1.18 | 5.03 | 30.05 | 0.33 | 0.47 |
Total Liabilities | 30.78 | 32.02 | 23.33 | 48.93 | 18.51 | 22.18 |
Common Stock | 0.01 | 0.01 | 0 | - | 0.01 | 0.02 |
Additional Paid-in Capital | 1,122 | 1,100 | 870.5 | 706.42 | 677.38 | 578.61 |
Accumulated Other Comprehensive Income | -0.28 | -0.29 | -0.26 | -0.23 | -0.17 | -0.09 |
Retained Earnings | -894.91 | -854.72 | -730.69 | -600.66 | -470.04 | -359.82 |
Shareholders' Equity | 227.14 | 245.15 | 139.56 | 105.53 | 207.18 | 218.72 |
Total Liabilities & Equity | 257.91 | 277.17 | 162.89 | 154.46 | 225.69 | 240.9 |
Total Debt | 1.29 | 1.31 | 8.12 | 9.81 | 0.76 | 0.96 |
Net Cash (Debt) | 184.18 | 206.33 | 90.66 | 15.14 | 119.47 | 177.7 |
Net Cash Growth | -10.73% | 127.59% | 498.99% | -87.33% | -32.77% | 134.57% |
Net Cash Per Share | 17.64 | 24.24 | 123.12 | 1909.78 | 65446.33 | 312109.10 |
Book Value | 227.14 | 245.15 | 139.56 | 105.53 | 207.18 | 218.72 |
Book Value Per Share | 21.76 | 28.80 | 189.53 | 13315.50 | 113496.00 | 384142.00 |
Tangible Book Value | 227.02 | 245.03 | 139.44 | 94.82 | 207.06 | 218.72 |
Tangible Book Value Per Share | 21.75 | 28.79 | 189.37 | 11964.30 | 113431.00 | 384142.00 |